student
UDK 61 Медицина. Охрана здоровья
Chronic venous disease is one of the most discussed diagnoses in surgery and occurs in about 25-50% of the adult population. The high prevalence of chronic venous disease in our country underlines the importance of accurate and modern diagnosis of this pathology, the need to use treatment technologies that can be applied as widely as possible, not only by cardiovascular doctors, phlebologists, but also specialists in general surgery and even doctors of other specialties. The Detralex line of drugs was created for the treatment of venous diseases: varicose veins and hemorrhoids. Detralex helps to relieve pain, swelling and heaviness in the legs in chronic venous disease, and in addition, helps to eliminate the symptoms of both acute and chronic hemorrhoids: discomfort, pain and bleeding.
chronic venous disease, Detralex, Detragel
1. Seliverstov E.I., Avak'yanc I.P., Nikishkov A.S., Zolotuhin I.A. Epidemiologiya hronicheskih zabolevaniy ven, Flebologiya, 2016:10 (1):35-43
2. Savel'ev V.S., Kirienko A.I., Zolotuhin I.A., Seliverstov E.I. Prospektivnoe observacionnoe issledovanie SPEKTR: registr pacientov s hronicheskimi zabolevaniyami ven nizhnih konechnostey, Flebologiya. 2012;6(1):4-9
3. Klinicheskie rekomendacii «Varikoznoe rasshirenie ven nizhnih konechnostey», 2021, 163 s.
4. Zolotukhin I, Seliverstov E, Shevtsov Y, Avakiants IP, Nikishkov AS, Ta- tarintsev AM, Kirienko AI. Prevalence and risk factors for chronic venous disease in the general russian population. European Journal of Vascular and Endovascular Surgery. 2017;54(6):752-758. https://doi.org/10.1016/j.ejvs.2017.08.033
5. Lekarstvennye preparaty v Rossii: Spravochnik Vidal' [Elektronnyy resurs]. - Elektron. dan. - Rezhim dostupa: http://www.vidal.ru.
